Oncogenic activation of the ret protooncogene in thyroid cancer

Medicine and Dentistry

• Cell Surface 25%
• Clinical Feature 25%
• Cysteine 25%
• Disulfide 25%
• Germline Mutation 25%
• Medullary Carcinoma 25%
• Multiple Endocrine Neoplasia 100%
• Multiple Endocrine Neoplasia Type 2a 25%
• Multiple Endocrine Neoplasia Type 2b 25%
• Papillary Carcinoma 25%
• Papillary Thyroid Cancer 50%
• Pheochromocytoma 25%
• Point Mutation 25%
• Protein Ret 50%
• Protein Tyrosine Kinase 50%
• Proto Oncogene 100%
• Radiation Exposure 25%
• Somatics 25%
• Thyroid Cancer 100%
• Thyroid Medullary Carcinoma 50%
• Thyroid Tumor 25%

Keyphrases

• Cell Surface 16%
• Chernobyl Accident 16%
• Clinical Features 16%
• Cysteine Residues 16%
• Dimerization 33%
• Disulfide 16%
• Extracellular Domain 16%
• Germline mutation 16%
• Medullary Carcinoma 16%
• Medullary Thyroid Carcinoma 33%
• Multiple Endocrine Neoplasia Type 2 (MEN2) 100%
• Oncogene 100%
• Papillary Carcinoma 16%
• Papillary Thyroid Carcinoma 33%
• Pheochromocytoma 16%
• Radiation Exposure 16%
• Single-point mutation 16%
• Somatic Rearrangement 16%
• Thyroid Cancer 100%
• Thyroid Tumor 16%
• Tyrosine Kinase 33%
• Tyrosine Kinase Domain 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Feature 25%
• Cysteine 25%
• Disulfide 25%
• Medullary Carcinoma 25%
• Multiple Endocrine Neoplasia 100%
• Multiple Endocrine Neoplasia Type 2a 25%
• Multiple Endocrine Neoplasia Type 2b 25%
• Papillary Carcinoma 25%
• Pheochromocytoma 25%
• Protein Ret 50%
• Protein Tyrosine Kinase 50%
• Radiation Exposure 25%
• Thyroid Cancer 100%
• Thyroid Medullary Carcinoma 50%
• Thyroid Papillary Carcinoma 50%
• Thyroid Tumor 25%